造血干细胞移植
干细胞
造血
下调和上调
移植
医学
免疫学
体内
癌症研究
生物
内科学
细胞生物学
基因
生物化学
生物技术
作者
Ran Zhang,Weijie Cao,Li Li,Dingming Wan,Zhongxing Jiang,Kai Sun,Linghui Xia
出处
期刊:Blood
[Elsevier BV]
日期:2020-11-05
卷期号:136 (Supplement 1): 4-4
被引量:9
标识
DOI:10.1182/blood-2020-139390
摘要
Endothelial microparticles (EMPs) upregulation has been observed in the pathological process of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The biological role and therapeutic potential of long non-coding RNAs (lncRNAs) carried by EMPs in aGVHD after allo-HSCT are still open questions. Herein, we investigated the functional significance of the lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) delivered by EMPs in aGVHD. To address this question, in the present study, we performed a comprehensive analysis of the lncRNA NEAT1 expression and EMPs in aGVHD by a series of in vivo and in vitro experiments. We found that expressions of lncRNA NEAT1 in MPs were remarkably elevated in aGVHD mice than in non-aGVHD mice. Furthermore, the lncRNA NEAT1 levels in the MPs were remarkably higher than those in the plasma of the aGVHD mice. We then used TNF-α (100 ng/ml) to stimulate primary mouse aortic endothelial cells (MAECs) to shed EMPs, and the expression of lncRNA NEAT1 in the EMPs and their maternal cells was compared. The lncRNA NEAT1 levels in the EMPs produced by TNF-α-stimulated MAECs were significantly higher than that in both their maternal cells and non-stimulated EMPs. Our study demonstrates that EMPs could assemble and concentrate lncRNA NEAT1. Taken together, NEAT1 delivered by EMPs could be used as a diagnostic and prognostic surrogate marker for aGVHD, and its targeting could therefore represent a promising strategy for novel therapeutic options in life-threatening aGVHD after allo-HSCT. Disclosures No relevant conflicts of interest to declare.
科研通智能强力驱动
Strongly Powered by AbleSci AI